Table 1.
No. of Barrett esophagus patients |
|||||
---|---|---|---|---|---|
Protein expression | without dysplasia (n = 22) | with dysplasia (n = 37) | with esophageal adenocarcinoma (n = 11) | P | effect |
MutL homologue 1 |
|||||
lost |
11 |
12 |
9 |
0.014 |
0.330* |
positive |
11 |
25 |
2 |
||
MutS homologue 2 |
|||||
lost |
4 |
0 |
0 |
0.019 |
0.342* |
positive |
18 |
37 |
11 |
||
Postmeiotic segregation increased 2 |
|||||
lost |
12 |
13 |
9 |
0.019 |
0.318* |
positive |
10 |
24 |
2 |
||
MutS homologue 6 |
|||||
lost |
4 |
0 |
0 |
0.018 |
0.342* |
positive |
18 |
37 |
11 |
||
Tumor protein p53 |
|||||
negative |
3 |
5 |
2 |
>0.999 |
|
positive | 19 | 32 | 9 |
*χ2 test.